HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 303 filers reported holding HAEMONETICS CORP in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,660,020 | -21.3% | 119,000 | -25.2% | 0.46% | -20.3% |
| Q2 2023 | $13,537,260 | +2.9% | 159,000 | 0.0% | 0.57% | -0.9% |
| Q1 2023 | $13,157,250 | -9.1% | 159,000 | -13.6% | 0.58% | -12.3% |
| Q4 2022 | $14,471,600 | +6.2% | 184,000 | 0.0% | 0.66% | -6.1% |
| Q3 2022 | $13,622,000 | +10.6% | 184,000 | -2.6% | 0.70% | +16.9% |
| Q2 2022 | $12,319,000 | +3.1% | 189,000 | 0.0% | 0.60% | +19.3% |
| Q1 2022 | $11,949,000 | +63.2% | 189,000 | +37.0% | 0.50% | +76.8% |
| Q4 2021 | $7,320,000 | -5.7% | 138,000 | +25.5% | 0.28% | -11.0% |
| Q3 2021 | $7,765,000 | +29.5% | 110,000 | +22.2% | 0.32% | +31.8% |
| Q2 2021 | $5,998,000 | -10.0% | 90,000 | +50.0% | 0.24% | -16.3% |
| Q1 2021 | $6,661,000 | -6.5% | 60,000 | 0.0% | 0.29% | -10.5% |
| Q4 2020 | $7,125,000 | +63.3% | 60,000 | +20.0% | 0.32% | +46.8% |
| Q3 2020 | $4,363,000 | +94.9% | 50,000 | +100.0% | 0.22% | +81.8% |
| Q2 2020 | $2,239,000 | – | 25,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |